Results 11 to 20 of about 4,773,777 (394)

Therapeutic plasma exchange in liver failure

World Journal of Hepatology, 2021
The multi-organ failure syndrome associated with acute and acute-on-chronic liver failure (ACLF) is thought to be mediated by overwhelming systemic inflammation triggered by both microbial and non-microbial factors.
Abimbola Chris-Olaiya, A. Kapoor, K. Ricci, Christina C. Lindenmeyer   +3 more
semanticscholar   +1 more source

Effect of plasma exchange on in-hospital mortality in patients with pulmonary hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: A propensity-matched analysis using a nationwide administrative database. [PDF]

PLoS ONE, 2018
Secondary pulmonary hemorrhage increases the risk of mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV); plasma exchange therapy may improve outcomes in these patients.
Eishi Uechi, Masato Okada, Kiyohide Fushimi   +2 more
doaj   +1 more source

Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient PreferencesPlain Language Summary

Kidney Medicine, 2023
Rationale & Objective: We sought to elicit patient preferences regarding the use of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and its tradeoffs of risk of kidney failure and risk of serious infection.
David Collister, Mark Farrar, Lesha Farrar, Paul Brown, Michelle Booth, Tracy Firth, Alfred Mahr, Linan Zeng, Mark A. Little, Reem A. Mustafa, Lynn A. Fussner, Alexa Meara, Gordon Guyatt, David Jayne, Peter A. Merkel, Michael Walsh   +15 more
doaj   +1 more source

Therapeutic plasma exchange in amatoxin associated acute liver failure-results from the multi-center Amanita-PEX study. [PDF]

Crit Care
Stahl K, Nalbant B, Pape T, Breteau I, Coirier V, Cardoso FS, de Haan J, Janik MK, Wasmuth JC, Madaleno J, Merle U, Frohme J, Tepasse PR, Müller M, Große K, Linke A, Mareljic N, Larsen FS, Dahlqvist G, Kolev M, Schulze M, Willuweit K, Janke-Maier P, Dondorf F, Fierro-Angulo ÓM, Geerts A, Toapanta D, Dejean C, Alharthi M, Reverter E, Schenk H, Raevens S, Macías-Rodríguez RU, Rauchfuß F, Berg CP, Schmidt H, Geier A, Semmo N, Lanthier N, Bjerring PN, Lange CM, Sterneck M, Bruns T, Schmid S, van de Loo D, Demir M, Boettler T, Borges C, Nattermann J, Wronka K, den Hoed CM, Marques HP, Artru F, Levesque E, Wedemeyer H, Campos-Murguia A, Taubert R, Amanita-PEX-study group.   +57 more
europepmc   +2 more sources

Clinical efficacy of plasma exchange in patients with autoimmune encephalitis

Annals of Clinical and Translational Neurology, 2021
To determine the clinical and antibody response after therapeutic plasma exchange (TPE) in patients with severe refractory antibody‐associated autoimmune encephalitis (AE).
Yan Zhang, Huijin Huang, Weibi Chen, Gang Liu, Fang Liu, Yingying Su   +5 more
semanticscholar   +1 more source

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.

New England Journal of Medicine, 2020
BACKGROUND More effective and safer treatments are needed for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. METHODS We conducted a randomized trial with a 2-by-2 factorial design to evaluate the use of plasma exchange and two ...
M. Walsh, P. Merkel, C. Peh, W. Szpirt, X. Puéchal, S. Fujimoto, C. Hawley, N. Khalidi, O. Flossmann, R. Wald, L. Girard, A. Levin, G. Gregorini, L. Harper, W. Clark, C. Pagnoux, U. Specks, L. Smyth, V. Tesar, T. Ito-Ihara, J. D. de Zoysa, W. Szczeklik, L. Flores-Suárez, S. Carette, L. Guillevin, C. Pusey, A. Casian, B. Brezina, Andrea Mazzetti, Carol A. McAlear, E. Broadhurst, DM Reidlinger, S. Mehta, N. Ives, D. Jayne   +34 more
semanticscholar   +1 more source

Plasma Exchange and Plasma Adsorption

JAPANES JOURNAL OF MEDICAL INSTRUMENTATION, 1992
T Agishi
openaire   +3 more sources

Case Report: High-dose immunoglobulins prior to plasma exchange in severe pulmonary renal syndrome

Frontiers in Immunology, 2023
Plasma exchange rapidly depletes pathogenic anti-neutrophil cytoplasmic autoantibodies (ANCAs) and is considered for induction therapy in severe ANCA-associated vasculitis.
Ann-Kathrin Schäfer, Sascha Dierks, Moritz Schnelle, Peter Korsten, Samy Hakroush, Björn Tampe   +5 more
doaj   +1 more source

A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19

Critical Care, 2020
The novel coronavirus (“SARS-CoV-2”) outbreak has created a sense of panic globally and has the medical community rapidly searching for answers. An estimated 100,000 individuals have already been infected with nearly 3300 deaths attributed to the disease
Philip Keith, M. Day, Linda A. Perkins, L. Moyer, Kristi Hewitt, Adam H. Wells   +5 more
semanticscholar   +1 more source

A regimen with caplacizumab, immunosuppression and plasma exchange prevents unfavorable outcomes in immune-mediated TTP.

Blood, 2020
The anti-von Willebrand factor nanobody caplacizumab was licensed for adults with immune-mediated thrombotic thrombocytopenic purpura (iTTP) based on prospective controlled trials. However, few data are available on post-marketing surveillance.
P. Coppo, M. Bubenheim, É. Azoulay, L. Galicier, Sandrine Malot, N. Bigé, P. Poullin, F. Provôt, Nihal Martis, C. Presne, O. Moranne, R. Benainous, A. Dossier, A. Séguin, M. Hié, A. Wynckel, Yahsou Delmas, J. Augusto, P. Pérez, V. Rieu, C. Barbet, F. Lhôte, M. Ulrich, A. Rumpler, S. de Witte, T. Krummel, A. Veyradier, Y. Benhamou   +27 more
semanticscholar   +1 more source